Quotient Bioscience

Quotient Bioscience is a rapidly growing UK Group focused on the provision of high value-added analytical and safety evaluation services and products for bioscience and sport. Founded in early 2007, Quotient Bioscience has completed four acquisitions in the United Kingdom – HFL Limited in January 2007; Alba Bioscience Limited in August 2007; GR Micro Limited in September 2007; and BioDynamics Research Limited in February 2008.

Quotient Bioscience reorganized its drug development services business under the Quotient Bioresearch name in May 2008. With its services focused on radiosynthesis, drug metabolism, bioanalysis, biomarkers and microbiology, the drug development services business of Quotient Bioresearch serves over 140 pharmaceutical and biotechnology companies worldwide (including many of the worlds most important pharmaceutical companies).